Prolonged administration of Mesalazine Enteric-Coated Tablets may lead to neurological disorders, dizziness, headache and other adverse effects, and sometimes gastrointestinal reactions such as abdominal pain, diarrhea, nausea, vomiting, and allergic rashes. Mesalazine enteric-coated tablets are commonly used in the treatment of ulcerative colitis, Crohn’s disease, etc. Common adverse reactions include aplastic anemia, dizziness, headache, arthralgia, elevated aminotransferase, elevated urea nitrogen, and so on. The use of this product is prohibited for those who are allergic to the drug, those with bleeding tendency, hepatic dysfunction, renal dysfunction. Pregnant as well as lactating women should use the drug with caution, and elderly patients should use the drug in a reduced dosage as appropriate. Taking the drug may cause liver and kidney function damage, regular review should be conducted during the period of taking the drug. The drug and glucocorticoids, sulfonylureas, spironolactone, furosemide, etc. together may have interaction, if you need to use the drug, should be standardized under the guidance of a doctor, do not long-term use, in order to avoid adverse reactions.